A principal component analysis of the proteins confirms the segregation of HPS-1 patients from healthy controls but does not segregate HPS-1 patients with IBD, HPS-1 patients with PF or HPS-1 patients with neither of these complications (Fig. 1h). This evidence concerns the gene HPS1 and inflammatory bowel disease.